Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
139
Frequently Asked Questions
What is Market Cap of Nykode Therapeutics AS?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Nykode Therapeutics AS market cap is $68.25M.
What is the 52-week high for Nykode Therapeutics AS?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Nykode Therapeutics AS 52 week high is $0.5257 as of September 06, 2025.
What is the 52-week low for Nykode Therapeutics AS?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Nykode Therapeutics AS 52 week low is $0.165 as of September 06, 2025.
What is Nykode Therapeutics AS stock price today?
Nykode Therapeutics AS stock price today is $0.209.
What was Nykode Therapeutics AS stock price yesterday?
Nykode Therapeutics AS stock price yesterday was $0.1651.
What is the PE ratio of Nykode Therapeutics AS?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Nykode Therapeutics AS’s P/E ratio is -4.00.
What is the Price-to-Book ratio of Nykode Therapeutics AS?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Nykode Therapeutics AS P/B ratio is 0.6641.
What is the 50-day moving average of Nykode Therapeutics AS?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Nykode Therapeutics AS 50-day moving average is $0.1898.
How many employess does Nykode Therapeutics AS has?
